about
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk fo...
Read More
17.31
-0.19
(-1.09%)
2.2M
XNAS Volume
XNAS 16 Jan, 2026 4:30 PM (EST)
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors
View Similar
Embed DVM
Adma Biologics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..